Drug‐Coated Balloons in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70240 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Deniz Mutlu und 31 weiteren Autor:innen. Beteiligte Einrichtung: Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Coronary Occlusion, Coated Materials, Biocompatible, Cardiac Catheters, Angioplasty, Balloon, Coronary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
There is limited information on the use of drug‐coated balloons (DCBs) in chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
Aims
To assess the frequency and outcomes of DCB use in CTO PCI.
Objective
This study evaluated the frequency and outcomes of DCB use in a large, multicenter CTO PCI registry.
Methods
We analyzed 12,146 patients who underwent 12,157 successful CTO PCIs at 59 centers from 2018 to 2025.
Results
DCBs were used in 454 patients (3.7%) with increasing frequency over time ( p = 0.020). A DCB‐only strategy was used in 48.4% of the patients and a hybrid strategy combining DCBs and drug‐eluting stents (DES) was used in 51.6% of patients. Patients treated with DCB (both strategies) had low prevalence of comorbidities. Compared with the DES cases, DCB only cases had favorable angiographic characteristics, lower mean J‐CTO (Japanese CTO) score (1.83 ± 1.03 vs. 2.27 ± 1.23; p < 0.001), and similar technical success (96.3% vs. 97.3%; p = 0.640), and in‐hospital major adverse cardiac events (MACE). The hybrid and DCB‐only strategies had comparable technical success and in‐hospital MACE. During a median follow‐up of 323 (170–429) days, DCB only cases had lower MACE than the other strategies (hazard ratio [HR] 0.41, 95% CI 0.17–0.96, p = 0.040). After multivariable adjustment, the association remained significant (HR 0.39, 95% CI 0.16–0.92, p = 0.032).
Conclusions
DCBs are increasingly being used in CTO PCI. A DCB only strategy was used in less complex lesions and was associated with similar technical success and in‐hospital MACE compared with hybrid or DES strategies. A DCB only strategy was associated with lower long‐term MACE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
- Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA.
- University of Washington, Seattle, Washington, USA.
- Massachusetts General Hospital, Boston, Massachusetts, USA.
- Western University, London, Ontario, Canada.
- Memorial Bahcelievler Hospital, Istanbul, Turkey.
ORCID-Profile: Deniz Mutlu, Athanasios Rempakos, Dimitrios Strepkos, Pedro E P Carvalho, Michaella Alexandrou, Eleni Kladou, Ozgur Selim Ser, Lorenzo Azzalini, Mahmut Uluganyan, Olga C Mastrodemos, Sandeep Jalli, Yader Sandoval, Emmanouil S Brilakis, Sevket Gorgulu
Zitieren
APA
Mutlu, D., Rempakos, A., Strepkos, D., Carvalho, P. E. P., Alexandrou, M., Kladou, E., Ser, O. S., Azzalini, L., Jaffer, F. A., Ybarra, L., Goktekin, O., Uluganyan, M., Ozdemir, R., Elbarouni, B., Alaswad, K., Davies, R., ElGuindy, A., Kocas, C., Sural, S., …, & Gorgulu, S. (2025). Drug‐Coated Balloons in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70240
Vancouver
Mutlu D, Rempakos A, Strepkos D, Carvalho PEP, Alexandrou M, Kladou E, et al. Drug‐Coated Balloons in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70240
BibTeX
@article{Mutlu2025,
author = {Mutlu, Deniz and Rempakos, Athanasios and Strepkos, Dimitrios and Carvalho, Pedro E P and Alexandrou, Michaella and Kladou, Eleni and Ser, Ozgur Selim and Azzalini, Lorenzo and Jaffer, Farouc A and Ybarra, Luiz and Goktekin, Omer and Uluganyan, Mahmut and Ozdemir, Ramazan and Elbarouni, Basem and Alaswad, Khaldoon and Davies, Rhian and ElGuindy, Ahmed and Kocas, Cuneyt and Sural, Sefa and Poommipanit, Paul and Frizzel, Jarrod and Basir, Mir B and Raj, Leah and Young, Laura and Rangan, Bavana V and Mastrodemos, Olga C and Sara, Jaskanwal Deep Singh and Jalli, Sandeep and Sandoval, Yader and Burke, M Nicholas and Brilakis, Emmanouil S and Gorgulu, Sevket},
title = {Drug‐Coated Balloons in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70240}
}
EUVIMED